|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date23 Dec 1964 |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
Inactive Indication- |
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date21 Mar 1962 |
100 Clinical Results associated with Eli Lilly Industries, Inc.
0 Patents (Medical) associated with Eli Lilly Industries, Inc.
100 Deals associated with Eli Lilly Industries, Inc.
100 Translational Medicine associated with Eli Lilly Industries, Inc.